首页> 美国卫生研究院文献>Nature Public Health Emergency Collection >Review of Clay-Drug Hybrid Materials for Biomedical Applications: Administration Routes
【2h】

Review of Clay-Drug Hybrid Materials for Biomedical Applications: Administration Routes

机译:生物医学应用的粘土-药物杂化材料综述:给药途径

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Focus here is placed on the pharmaceutical and biomedical applications of novel clay-drug hybrid materials categorized by methods of administration. Clay minerals have been used for many years as pharmaceutical and medicinal ingredients for therapeutic purposes. A number of studies have attempted to explore clay-drug hybrid materials for biomedical applications with desired functions, such as sustained release, increased solubility, enhanced adsorption, mucoadhesion, biocompatibility, targeting, The present review attempts not only to summarize the state-of-the-art of clay-drug hybrid materials and their advantages, depending on the methods of administration, but also to deal with challenges and future perspectives of clay mineral-based hybrids for biomedical applications.
机译:这里的重点放在通过给药方法分类的新型粘土-药物杂化材料的药物和生物医学应用上。粘土矿物质已被用作治疗目的的药物和药用成分多年。许多研究尝试探索具有所需功能(例如持续释放,增加的溶解度,增强的吸附,粘膜粘附,生物相容性,靶向性)的具有所需功能的生物医学应用的粘土-药物杂化材料。本综述不仅试图总结药物的状态。粘土-药物杂化材料的先进技术及其优势,取决于给药方法,还可以应对生物医学应用中基于粘土矿物的杂化材料的挑战和未来展望。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号